Clinical Trial Update: Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor [Phase 2]

View source ↗

Summary

This is a Phase 2 randomized study evaluating doxorubicin and cyclophosphamide with or without intermittent sunitinib as first-line treatment for locally advanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Sunitinib (sunitinib)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN